問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberDB-1311-O-1001
Active

2024-04-01 - 2028-01-31

Others

Not yet recruiting1

Recruiting9

ICD-10C45.9

Mesothelioma, unspecified

ICD-10C79.9

Secondary malignant neoplasm of unspecified site

ICD-10C7A.00

Malignant carcinoid tumor of unspecified site

ICD-10C7A.094

Malignant carcinoid tumor of the foregut NOS

ICD-10C7A.095

Malignant carcinoid tumor of the midgut NOS

ICD-10C7A.096

Malignant carcinoid tumor of the hindgut NOS

ICD-10C7A.1

Malignant poorly differentiated neuroendocrine tumors

ICD-10C7A.8

Other malignant neuroendocrine tumors

ICD-10C7B.00

Secondary carcinoid tumors, unspecified site

ICD-10C80.1

Malignant (primary) neoplasm, unspecified

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9199.1

Malignant neoplasm of unspecified site (primary) (secondary)

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Chao-Hua Chiu

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Wei-Hong Cheng

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chia-Chi Lin

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 饒坤銘

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 曹朝榮

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

The Actual Total Number of Participants Enrolled

0 Recruiting

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 張志隆

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Muh-Hwa Yang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator I-CHEN WU

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    70 participants

  • Global

    862 participants